Accelerate Diagnostics Inc
F:1A8
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Accelerate Diagnostics Inc
F:1A8
|
US |
|
B
|
Brainbees Solutions Ltd
NSE:FIRSTCRY
|
IN |
|
Eenergy Group PLC
LSE:EAAS
|
UK |
|
N
|
Nikon Corp
OTC:NINOF
|
JP |
|
L
|
Littelfuse Inc
SWB:LFS
|
US |
|
G
|
Gerresheimer AG
XMUN:GXI
|
DE |
|
LATAM Airlines Group SA
OTC:LTMAY
|
CL |
|
K
|
Kraft Heinz Co
BMV:KHC
|
US |
|
G
|
Gruppo MutuiOnline SpA
F:MNL
|
IT |
|
L
|
Legible Inc
F:D0T
|
CA |
|
G
|
Gladstone Commercial Corp
XBER:GLE
|
US |
|
Adaro Energy Indonesia TBK PT
OTC:ADOOY
|
ID |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
US |
|
C
|
Cognizant Technology Solutions Corp
XHAM:COZ
|
US |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1A8's stock price target?
Not Available
1A8 does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Accelerate Diagnostics Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 1 year is 7%.